Middle East and Africa Human Vaccines Market Information, by Technology (Attenuated, Inactivated, Toxoid, Conjugate, & Subunit, Recombinant DNA), Disease Indication (Pneumococcal, Influenza, Hepatitis, Rotavirus, DTP, Polio, others), by Type (Prophylactic and Therapeutic); by Composition (Mono Vaccine and Combination Vaccines) by End User (children and adults) and by Route of Administration (Oral, Injectable And Other) – Forecast till 2022
Taking all the factors into consideration, we expect the Middle East and Africa human vaccines market which was $ 2.8 billion in 2015 to reach around $ 5.46 billion in future, growing at a CAGR of 11.8%.
KEY PLAYERS FOR MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET
GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Shenzhen Kangtai Biological Products, Valeant Pharmaceuticals, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec and others.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2671 .
MARKET SCENARIO FOR MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET
A vaccine is a biological preparation which contains a weakened or killed microbial agent, its toxins or its surface proteins, which provides active acquired immunity against the disease caused by the microbe.
The aim of vaccination is to stimulate and train the body immunity to recognize and destroy the microbial threat in later encounters. Vaccination is the most effective method of preventing infectious diseases and is largely responsible for eradicating many deadly diseases such as smallpox and the restriction of diseases such as measles, and tetanus.
Middle East and Africa are laggards when it comes to immunization coverage. According to World Health Organization (WHO), out of the total number of children worldwide who did not receive the required three doses of diphtheria-tetanus-pertussis vaccines, more than 40% were from sub-Saharan Africa. Other nations with large unvaccinated population include Nigeria, Iraq, Chad, Niger, Angola, Somalia and Sudan. UNICEF estimates that in 2015, Central African Republic, Equatorial Guinea, Somalia, South Sudan, Syrian Arab Republic and Ukraine had less than 50%coverage of the third dose of diphtheria, tetanus and pertussis (DTP) vaccine. More than half of the unvaccinated children live in Democratic Republic of Congo, Ethiopia, India, Indonesia, Iraq, Nigeria, Pakistan, Philippines, Uganda and South Africa.
Thus Middle East and Africa offer immense potential and opportunities for the vaccine market. Apart from the unmet needs for vaccination, second most important market driving factor are the policies of national Governments and international bodies such as World health organization (WHO). For example vaccine action plan of WHO along with huge funding from international bodies were responsible for driving the vaccine market to great heights in the past and also resulted in development and expansion of vaccine production capacities especially in developing states notably India. Other driving factors are increasing funds from philanthropy organizations such as Bill and Melinda Gates foundation, inclusion of several new vaccines in the national immunization schedule of many countries, development of new vaccines which includes vaccine for hepatitis, growing awareness of vaccination, growth of manufacturing low cost vaccines especially in developing countries, the entry of China in the vaccine market etc.
SEGMENTS FOR MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET
Middle East and Africa human vaccines market has been segmented on the basis of technology which comprises attenuated, inactivated, toxoid, conjugate & subunit, recombinant DNA. On the basis of disease indication; a market is segmented into pneumococcal, influenza, hepatitis, rotavirus, DTP, polio and others. On the basis of type the market is segmented into prophylactic and therapeutic. On the basis of composition, market is again segmented into mono vaccine and combination vaccines. The route of administration segments the market into oral, injectable and other. Moreover on the basis of end user; a market is segmented into children and adults.
REGIONAL ANALYSIS FOR MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET
Depending on the geographic region, human vaccine market is segmented into several countries: UAE is the largest market for human vaccines in the entire Middle East and Africa human vaccines market closely followed by Egypt. The rest of Africa’s market especially Sub Saharan regions are however the fastest growing market with a huge unmet medical needs.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2671 .
MAJOR TOC FOR MIDDLE EAST AND AFRICA HUMAN VACCINES MARKET
CHAPTER 1. INTRODUCTION
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
CHAPTER 2. RESEARCH METHODOLOGY
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
CHAPTER 3. MARKET DYNAMICS
3.5 Macroeconomic Indicators
CHAPTER 4. MARKET FACTOR ANALYSIS
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat of New Entrants
Ask to Expert Inquire @ https://www.marketresearchfuture.com/enquiry/2671 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312